DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
25 hedge funds and large institutions have $179K invested in DMK Pharmaceuticals Corporation Common Stock in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
25
Holding in Top 10
–
Calls
$75K
Puts
–
Top Buyers
| 1 | +$24.2K | |
| 2 | +$22.8K | |
| 3 | +$20.5K | |
| 4 |
VF
Virtu Financial
New York
|
+$13K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11.8K |
Top Sellers
| 1 | -$32.9K | |
| 2 | -$565 | |
| 3 | -$171 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$65 |
| 5 |
Morgan Stanley
New York
|
-$12 |